We Are Honored to be Named As One of TIME Magazine's 50 Genius Companies For Our Work in Advancing Cannabinoid Science

Our Story

We've achieved this distinction through innovation and persistence.

 

Medical Information

Access scientific and clinical information on Greenwich Biosciences products.

READ MORE

Spotlight News

Spotlight News
Mar 20, 2019
Overcoming Challenges in the Diagnosis of Rare Childhood-onset Epilepsies
READ MORE >

Press Releases

May 6, 2019
Greenwich Biosciences Reports Positive Phase 3 Pivotal Trial Results for EPIDIOLEX® (cannabidiol) Oral Solution in Patients with Seizures Associated With Tuberous Sclerosis Complex
Read More >

Patients & Caregivers

“Our primary purpose is to make a positive and meaningful difference in the lives of patients and their caregivers.”

–Justin Gover,
Chief Executive Officer 

 

Careers

Become part of a dynamic, cutting-edge pharmaceutical company on the forefront of a new category of therapeutic treatment.